Drug intelligence / Profile preview

Purethal

Development stage
Phase 4
Lead developer
HAL Allergy
Modality
Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

Purethal is a brand of allergen immunotherapy products developed for the treatment and prevention of allergic diseases such as allergic rhinitis (hay fever), allergic conjunctivitis, and hypersensitivity reactions. The product line includes formulations targeting specific allergens like grass pollen (Purethal Grasses) and house dust mites (PURETHAL Mites). These are therapeutic vaccines that work by gradually exposing patients to increasing doses of allergen extracts via subcutaneous injection, thereby stimulating the immune system to develop tolerance to these allergens. This process reduces symptoms upon natural exposure. The mechanism of action is immunostimulation through controlled allergen exposure. Purethal is primarily indicated for IgE-mediated allergies confirmed by diagnostic testing[7][9].

Brand names
PurethalPurethal GrassesPURETHAL Mites
02

Targets

TCR (T cell antigen receptor complex)

Beyond the preview

Go deeper on Purethal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purethal.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call